相似文献
1
AnchorQuery: Rapid online virtual screening for small-molecule protein-protein interaction inhibitors.
Protein Sci. 2018 Jan;27(1):229-232. doi: 10.1002/pro.3303. Epub 2017 Oct 24.
2
Pharmit: interactive exploration of chemical space.
Nucleic Acids Res. 2016 Jul 8;44(W1):W442-8. doi: 10.1093/nar/gkw287. Epub 2016 Apr 19.
3
Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations.
Protein Sci. 2020 Jan;29(1):76-86. doi: 10.1002/pro.3732. Epub 2019 Dec 4.
4
ZINCPharmer: pharmacophore search of the ZINC database.
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W409-14. doi: 10.1093/nar/gks378. Epub 2012 May 2.
5
Focusing on shared subpockets - new developments in fragment-based drug discovery.
Expert Opin Drug Discov. 2015;10(11):1179-87. doi: 10.1517/17460441.2015.1080684. Epub 2015 Aug 21.
6
Structure-Based Virtual Screening of Commercially Available Compound Libraries.
Methods Mol Biol. 2016;1439:65-76. doi: 10.1007/978-1-4939-3673-1_4.
7
ChemScreener: A Distributed Computing Tool for Scaffold based Virtual Screening.
Comb Chem High Throughput Screen. 2015;18(6):544-61. doi: 10.2174/1386207318666150703112242.
8
VSPrep: A General KNIME Workflow for the Preparation of Molecules for Virtual Screening.
Mol Inform. 2017 Oct;36(10). doi: 10.1002/minf.201700023. Epub 2017 Jun 6.
9
Enabling large-scale design, synthesis and validation of small molecule protein-protein antagonists.
PLoS One. 2012;7(3):e32839. doi: 10.1371/journal.pone.0032839. Epub 2012 Mar 12.
10
Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
J Mol Graph Model. 2015 Mar;56:20-30. doi: 10.1016/j.jmgm.2014.11.015. Epub 2014 Dec 5.
引用本文的文献
1
Scaffold-hopping for molecular glues targeting the 14-3-3/ERα complex.
Nat Commun. 2025 Jul 14;16(1):6467. doi: 10.1038/s41467-025-61176-4.
2
Exploring chemical space for "druglike" small molecules in the age of AI.
Front Mol Biosci. 2025 Mar 17;12:1553667. doi: 10.3389/fmolb.2025.1553667. eCollection 2025.
3
Computational Tools and Strategies to Develop Peptide-Based Inhibitors of Protein-Protein Interactions.
Methods Mol Biol. 2022;2405:205-230. doi: 10.1007/978-1-0716-1855-4_11.
4
The Groebke-Blackburn-Bienaymé Reaction.
Eur J Chem. 2019 Nov 14;2019(42):7007-7049. doi: 10.1002/ejoc.201901124. Epub 2019 Aug 30.
5
Developing a machine learning model to identify protein-protein interaction hotspots to facilitate drug discovery.
PeerJ. 2020 Dec 7;8:e10381. doi: 10.7717/peerj.10381. eCollection 2020.
6
Scanning Protein Surfaces with DNA-Encoded Libraries.
ChemMedChem. 2021 Apr 8;16(7):1048-1062. doi: 10.1002/cmdc.202000869. Epub 2020 Dec 28.
7
Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach.
ChemMedChem. 2020 Apr 20;15(8):680-684. doi: 10.1002/cmdc.202000024. Epub 2020 Mar 18.
8
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace.
Brief Bioinform. 2021 Mar 22;22(2):1790-1818. doi: 10.1093/bib/bbaa034.
9
Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction.
Eur J Med Chem. 2019 Nov 15;182:111588. doi: 10.1016/j.ejmech.2019.111588. Epub 2019 Aug 6.
10
Artificial Macrocycles.
Synlett. 2018 Jun;29(9):1136-1151. doi: 10.1055/s-0036-1591975. Epub 2018 May 7.
本文引用的文献
1
Scaffold hopping via ANCHOR.QUERY: β-lactams as potent p53-MDM2 antagonists.
Medchemcomm. 2017 May 1;8(5):1046-1052. doi: 10.1039/C7MD00058H. Epub 2017 Mar 15.
2
Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction.
Eur J Med Chem. 2017 Jan 27;126:384-407. doi: 10.1016/j.ejmech.2016.11.029. Epub 2016 Nov 16.
3
Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods.
Angew Chem Int Ed Engl. 2015 Nov 16;54(47):13933-6. doi: 10.1002/anie.201506310. Epub 2015 Sep 4.
4
PocketQuery: protein-protein interaction inhibitor starting points from protein-protein interaction structure.
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W387-92. doi: 10.1093/nar/gks336. Epub 2012 Apr 20.
5
Chemistry and biology of multicomponent reactions.
Chem Rev. 2012 Jun 13;112(6):3083-135. doi: 10.1021/cr100233r. Epub 2012 Mar 22.
6
Enabling large-scale design, synthesis and validation of small molecule protein-protein antagonists.
PLoS One. 2012;7(3):e32839. doi: 10.1371/journal.pone.0032839. Epub 2012 Mar 12.
7
Pharmer: efficient and exact pharmacophore search.
J Chem Inf Model. 2011 Jun 27;51(6):1307-14. doi: 10.1021/ci200097m. Epub 2011 Jun 2.
8
Anchor residues in protein-protein interactions.
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11287-92. doi: 10.1073/pnas.0401942101. Epub 2004 Jul 21.
9
Diversity of protein-protein interactions.
EMBO J. 2003 Jul 15;22(14):3486-92. doi: 10.1093/emboj/cdg359.
10
"Multi-component reactions : emerging chemistry in drug discovery" 'from xylocain to crixivan'.
Curr Med Chem. 2003 Jan;10(1):51-80. doi: 10.2174/0929867033368600.
Zotero 插件